Neumirna Therapeutics, a biotechnology company developing RNA-based therapies for neurological diseases, today announced the appointment of Ellen K. Donnelly, Ph.D. as Chief Executive Officer.

Global Sumud Flotilla reports harassment near Greece; UN calls for a probe as European ships move to safeguard civilians at ...

Gene therapy for Huntington’s disease, a rare degenerative brain disorder, has succeeded for the first time in the United ...

In six massive laboratory freezers at the University of Utah, nearly 40,000 blood samples wait in frozen stasis.

The number of people living with dementia worldwide is projected to reach around 153 million by 2050, while in Australia, it ...

Unwanted hair growth, mood swings, acne, weight gain or difficulty losing weight, and irregular or absent periods are all signs that someone is going through puberty.But for one in eight women ...

We’ve come too far to go back to a time when autism was defined solely in terms of deficits and mothers were made to feel guilty.

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with the Italian Medicines Agency (AIFA) for eligible transfusion-dependent beta thalassemia (TDT) and severe sickle ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — if pharmaceutical companies would allow it.

The pharmaceutical industry, with its wealth of sensitive data and critical research, must remain at the forefront of cybersecurity efforts. By integrating cybersecurity considerations into every ...

Modernizing Clinical Trials: A Site-Centered Roadmap for the Future Simplifying startup, empowering sites through networks, ...

Frank Menniti shares lab space for his work as chief science officer for a company developing a new drug for Alzheimer’s ...